Home › Johnson & Johnson Faces Uphill Battle At FDA Advisory Panel
 

Keywords :   


Johnson & Johnson Faces Uphill Battle At FDA Advisory Panel

2014-01-15 00:47:09| Food - Topix.net

The third time may not be the charm. Twice before the FDA has turned down the supplemental new drug application for an acute coronary syndrome indication for Johnson & Johnson's Xarelto .

Tags: panel johnson battle faces

Category:Food and Related Products

Latest from this category

All news
»
19.05Cashing In On The Stache
19.05 Dr. Squatch Launches Bronco Bricc
19.05Gillette Venus Announces Ambassadors Ahead of the Olympic and Paralympic Games Paris 2024
19.05Eastern North Pacific Tropical Weather Outlook
19.05Atlantic Tropical Weather Outlook
19.05Eastern North Pacific Tropical Weather Outlook
19.05Atlantic Tropical Weather Outlook
19.05'I had no choice but to get a 35-year mortgage'
More »